Details

Klinični pomen določanja prekurzorja prostatno specifičnega antigena pri bolnikih z nizko celokupno plazemsko koncentracijo specifičnega antigena : magistrski študij laboratorijske biomedicine
ID Bizjak, Mitja (Author), ID Osredkar, Joško (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/bizjak_mitja_mag_nal_2016.pdf?sfvrsn=2 This link opens in a new window

Language:Slovenian
Keywords:rak prostate, prostatično specifični antigen, prostatični indeks, razmerje med koncntracijo prostega PSA in celotnega PSA, tumorski označevalec, določanje prekurzorja
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[M. Bizjak]
Year:2016
Number of pages:VIII, 59 f.
PID:20.500.12556/RUL-87336 This link opens in a new window
UDC:616.65-006(043.3)
COBISS.SI-ID:4116081 This link opens in a new window
Publication date in RUL:08.12.2016
Views:2501
Downloads:416
Metadata:XML DC-XML DC-RDF
:
BIZJAK, Mitja, 2016, Klinični pomen določanja prekurzorja prostatno specifičnega antigena pri bolnikih z nizko celokupno plazemsko koncentracijo specifičnega antigena : magistrski študij laboratorijske biomedicine [online]. Master’s thesis. Ljubljana : M. Bizjak. [Accessed 12 June 2025]. Retrieved from: http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/bizjak_mitja_mag_nal_2016.pdf?sfvrsn=2
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Clinical value of precursor prostate specific antigen in patients with low plasma concentration of prostate specific antigen

Similar documents

Similar works from RUL:
  1. Description of adverse event of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer treated at the University Clinic Golnik
  2. Antibiotic prescription patterns in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors and their association with treatment outcomes
  3. Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
  4. Characteristics of treatment with proton pump inhibitors among lung cancer patients treated with immunotherapy at the University Clinic Golnik
  5. Prescribing patterns of metformin and paracetamol and their association with treatment outcomes with immune checkpoint inhibitors in patients with non-small cell lung cancer
Similar works from other Slovenian collections:
  1. Vodnik za bolnike z nedrobnoceličnim pljučnim rakom v stadiju III
  2. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection
  3. Care of patients with non-small-cell lung cancer stage III
  4. Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy

Back